Received Dec 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 4 | U7947AA | IM / RL |
CMA administered Vaxelis at 15 month wcc instead of Daptacel. No adverse effects reported. This was identified on audit 11/28/2025. provider notified and no further interventions required at this time.
none
none
n/a